AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) shares traded up 0.6% during mid-day trading on Wednesday . The company traded as high as $1.74 and last traded at $1.72. 4,054 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 79,326 shares. The stock had previously closed at $1.71.
AIkido Pharma Stock Up 0.6 %
The business has a fifty day simple moving average of $1.82 and a 200-day simple moving average of $1.87. The firm has a market cap of $9.43 million, a P/E ratio of -0.44 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Recommended Stories
- Five stocks we like better than AIkido Pharma
- 3 REITs to Buy and Hold for the Long Term
- Tesla Poised to Hit Record Highs This Holiday Season
- Utilities Stocks Explained – How and Why to Invest in Utilities
- The Salesforce Rally is Just Getting Started: Here’s Why
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
